Phase 1, open-label, multicenter, dose escalation safety and tolerability study of oncolytic virus OVV-01 in advanced solid tumors
溶瘤病毒OVV-01治疗晚期实体瘤的I期、开放标签、多中心、剂量递增安全性和耐受性研究
期刊:Journal for ImmunoTherapy of Cancer
影响因子:10.6
doi:10.1136/jitc-2025-011517
Hua, Yingqi; Wang, Chongren; Li, Fan; Han, Yanjie; Zuo, Dongqing; Lv, Yu; Sun, Mengxiong; Yuan, Peng; Yuan, Ruirong; Zhang, Fan; Ma, Liang; Wang, Yan; Wu, Hui; Zhou, Guoqing; Lin, Qiang; Wang, Shuhang; Li, Ning; Lu, Yinying